Shedding stopped and micro inflammation is gone after adding dut 1.5 mg for 1 month
    Update 11/25/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 1.5 mg daily 1 month
    💊 Finasteride (oral) 1 mg 9 months
    💧 Minoxidil (topical)
    💧 Ketoconazole (topical) 3 months
    the tone is 😀 positive with impressive results.

    Other terms

    Dutasteride 1.5 mg stopped shedding and reduced scalp inflammation in one month, unlike finasteride. The user also uses minoxidil but saw no results until adding dutasteride.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Hair Loss in Women: Comprehensive Overview and Treatment Options

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.
      Rebalance of the Scalp Microbiota by a Multifunctional Ingredient

      research 203 Rebalance of the scalp microbiota by a multifunctional ingredient

      August 2016 in “Journal of Investigative Dermatology”
      This study found that Rosebay extract significantly reduced dandruff and sebum production, suggesting it may be an effective anti-dandruff ingredient as a complement or alternative to antifungal treatments.
      Frontal Fibrosing Alopecia: Increasing Cases and Treatment Options

      research Frontal fibrosing alopecia

      6 citations , January 2017 in “British Journal of Dermatology”
      This article reviews frontal fibrosing alopecia, exploring its characteristics, demographics, and associated conditions, and calls for controlled trials due to an increase in worldwide cases; it reports no new findings.